Details for New Drug Application (NDA): 020405
✉ Email this page to a colleague
NDA 020405 describes LANOXIN, which is a drug marketed by Azurity and Advanz Pharma and is included in two NDAs. It is available from three suppliers. Additional details are available on the LANOXIN profile page.
The generic ingredient in LANOXIN is digoxin. There is one drug master file entry for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
The generic ingredient in LANOXIN is digoxin. There is one drug master file entry for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
Summary for 020405
| Tradename: | LANOXIN |
| Applicant: | Advanz Pharma |
| Ingredient: | digoxin |
| Patents: | 0 |
Suppliers and Packaging for NDA: 020405
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| LANOXIN | digoxin | TABLET;ORAL | 020405 | NDA | Advanz Pharma (US) Corp. | 59212-240 | 59212-240-55 | 100 TABLET in 1 BOTTLE (59212-240-55) |
| LANOXIN | digoxin | TABLET;ORAL | 020405 | NDA | Advanz Pharma (US) Corp. | 59212-242 | 59212-242-55 | 100 TABLET in 1 BOTTLE (59212-242-55) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.0625MG | ||||
| Approval Date: | Sep 30, 1997 | TE: | AB | RLD: | Yes | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.125MG | ||||
| Approval Date: | Sep 30, 1997 | TE: | AB | RLD: | Yes | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.1875MG | ||||
| Approval Date: | Sep 30, 1997 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
